癌症患者的尼拉巴里布与高血压相关:基于FAERS数据库的药监测分析和随机对照试验的元分析
Wei Chen1, Jiyi Xie1, Chen Gao1
1Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Gynecologic oncology
|January 31, 2024
概括
与其他PARP抑制剂相比,Niraparib显著增加了高血压的风险,这是一个明显的不良事件. 早期识别和管理尼拉帕里布诱导的高血压对于患者护理至关重要.
科学领域:
- 在瘤学瘤学.
- 药物监督 药物监督 药物监督
- 临床药理学 临床药理学
背景情况:
- 尼拉帕里布是治疗卵巢癌的关键药物.
- 对临床医生来说,了解niraparib的高血压风险至关重要.
- 高血压是一种与niraparib相关的显著不良事件.
研究的目的:
- 评估与niraparib相关的高血压的发生率和风险.
- 为了将niraparib的高血压风险与其他PARP抑制剂进行比较.
- 强调在尼拉帕里布治疗中早期识别高血压的必要性.
主要方法:
- 使用FDA不良事件报告系统 (FAERS) 数据进行的回顾性药监测研究 (Q1 2017-Q1 2023).
- 不成比例性分析以评估尼拉帕里布相关的高血压.
- 对尼拉帕里布用于癌症治疗的随机对照试验 (RCT) 的元分析.
主要成果:
- 1196例高血压病例与FAERS中的niraparib相关;与其他PARP抑制剂相比,最大的不成比例 (ROR 2.85).
- 分析显示,尼拉帕里布与安慰剂 (OR 2.84) 相比,尼拉帕里布的高血压风险显著增加.
- 尼拉帕里布诱导的高血压发生率为16.9%,在RCT中没有异质性.
结论:
- 高血压是niraparib的一个独特的不良事件.
- 尼拉帕里布显著增加高血压风险,需要临床警.
- 早期检测和治疗尼拉帕里布诱导的高血压是必不可少的.
相关概念视频
Pharmacovigilance
833
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
833
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
163
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
163
Hazard Ratio
124
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
124
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
138
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
138
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
62
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
62
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
128
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
128


